Full-dose challenges for emergency department (ED) patients with moderate, severe, and unknown beta-lactam allergies can safely reduce unnecessary antibiotic regimens, cut costs, and preserve future ...

Please provide your email address to receive an email when new articles are posted on . Surgical patients with a documented beta-lactam allergy were nine times less likely to receive the preferred ...

Prolonged infusion of beta-lactam antibiotics for sepsis or septic shock tended to improve mortality compared with conventional intermittent infusion in the BLING III trial, and a meta-analysis ...

Please provide your email address to receive an email when new articles are posted on . De-escalation of beta-lactam antibiotics was associated with a decreased risk of new resistance among patients ...

Surgical antimicrobial prophylaxis using non-beta‑lactams administered before major surgery was independently associated with a significantly higher risk for surgical site infection than conventional ...

Data was compiled from electronic records for patients aged 3 months to 18 years who were diagnosed with CAP between 2009 and 2013. This article is written live from ID Week 2017 Annual Meeting in San ...

Critically ill sepsis patients did not fare better with prolonged infusions of meropenem compared with intermittent infusions of the beta-lactam antibiotic, a randomized trial showed. Among over 600 ...

The researchers compared the effectiveness of oral beta-lactams to fluoroquinolones in the treatment of Enterobacteriaceae bloodstream infections (EBSI) in adult patients. This article is written live ...

(Medical Xpress)—A team of researchers at pharmaceutical giant Merck has found a way to make anti-bacterial agents that have lost their ability to kill certain types of bacteria, become deadly again.